Cantor Fitzgerald Issues Positive Estimate for CAPR Earnings
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for Capricor Therapeutics in a note issued to investors on Tuesday, April 1st. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post earnings of ($1.11) per share for the year, up from […]
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for Capricor Therapeutics in a note issued to investors on Tuesday, April 1st. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post earnings of ($1.11) per share for the year, up from […]
